Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Detalles Bibliográficos
Autores principales: Gautret, Philippe, Hoang, Van Thuan, Lagier, Jean-Christophe, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779264/
https://www.ncbi.nlm.nih.gov/pubmed/33408029
http://dx.doi.org/10.1016/j.ijantimicag.2020.106239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779264/
https://www.ncbi.nlm.nih.gov/pubmed/33408029
http://dx.doi.org/10.1016/j.ijantimicag.2020.106239

Ejemplares similares